Group structure
10 companies in 3 countries
Loading…
10 companies in 3 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
19 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ANNOVERA0.013mg/24hr; 0.15mg/24hr · Ring | Ethinyl estradiol, Segesterone | United States | Marketed | 2018 |
| BIJUVA0.5mg; 100mg | 1mg; 100mg · Capsule | Estradiol, Progesterone | United States | Marketed | 2018 |
| DORYX100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 200MG BASE | 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons · Tablet, delayed release | Doxycycline | United States | Not marketed | 2005 |
| DORYX100mg base | 75mg base · Capsule, delayed release | Doxycycline | United States | Not marketed | 1985 |
| DORYX MPC120MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 60MG BASE · Tablet, delayed release | Doxycycline | United States | Marketed | 2005 |
| EPSOLAY5% · Cream | Benzoyl peroxide | United States | Marketed | 2022 |
| FABIOR0.1% · Aerosol, foam | Tazarotene | United States | Marketed | 2012 |
| IMVEXXY0.004mg | 0.01mg · Insert | Estradiol | United States | Marketed | 2018 |
| LEXETTE0.05% · Aerosol, foam | Ulobetasol | United States | Not marketed | 2018 |
| NEXTSTELLIS3mg; 14.2mg · Tablet | Drospirenona, Estetrol | United States | Marketed | 2021 |
| RHOFADE1% · Cream | Oxymetazoline | United States | Marketed | 2017 |
| SOLTAMOX20mg base/10ml · Solution | Tamoxifen | United States | Marketed | 2005 |
| SORILUX0.005% · Aerosol, foam | Calcipotriene | United States | Marketed | 2010 |
| TOLSURA65mg · Capsule | Itraconazole | United States | Marketed | 2018 |
| TWYNEO3%; 0.1% · Cream | Benzoyl peroxide, Tretinoin | United States | Marketed | 2021 |
| Rozlytrek | Entrectinib | Saudi Arabia | Authorised | |
| ETHINYL ESTRADIOL; LEVONORGESTREL0.02mg,0.15mg; 0.025mg,0.15mg · Tablet | Ethinyl estradiol, Levonorgestrel | United States | tentative | 2017 |
| LUXIQ0.12 % · Aerosol (Foam) | Betamethasone | Canada | Cancelled | 2012 |
| OLUX-E0.05 % / w/w · Aerosol (Foam) | Clobetasol | Canada | Cancelled | 2013 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 16 | 15 | 1 | CompaniesAll medicines |
| Canada | 2 | 0 | 2 | CompaniesAll medicines |
| Saudi Arabia | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Australia, Colombia, Singapore, Sweden
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Licence: Creative Commons Attribution 3.0 Australia
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Keep Mayne’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.